Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions (Q47887699)

6 February 2018

title

Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions (English)

1 reference

6 February 2018

author

Paul A Heidenreich

5

1 reference

6 February 2018

author name string

William F Fearon

1

1 reference

6 February 2018

Alan C Yeung

2

1 reference

6 February 2018

David P Lee

3

1 reference

6 February 2018

Paul G Yock

4

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 February 2018

published in

American Heart Journal

1 reference

6 February 2018

volume

145

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

882-887

1 reference

6 February 2018

ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collabor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Analysis of coronary angioplasty practice in the United States with an insurance-claims data base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Practice and potential pitfalls of coronary pressure measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Fractional Flow Reserve in Patients With Prior Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to M

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

The effects of contemporary use of coronary stents on in-hospital mortality. Registry Committee of the Society for Cardiac Angiography and Interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900072-3

10.1016/S0002-8703(03)00072-3

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018